![]() |
Autoimmune Disorders |
Free Subscription
1 Brain |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.
Brain. 2025;148:1652-1664.
PubMed
Abstract available
Psychological and self care outcomes for children and adolescents living with
type 1 diabetes and their caregivers attending diabetes camp: A mixed methods
study.
Diabet Med. 2025 Apr 2:e70038. doi: 10.1111/dme.70038.
PubMed
Abstract available
Impact of ultrasound-diagnosed lipohypertrophy subtypes on insulin regimen
adjustments in patients with T1DM.
Diabet Med. 2025;42:e70034.
PubMed
Abstract available
Improved self-management of type 1 diabetes in young women: Experiences of Guided
Self-Determination-Young: A qualitative interview study.
Diabet Med. 2025 Mar 28:e70029. doi: 10.1111/dme.70029.
PubMed
Abstract available
Patient relevant outcomes for type 1 diabetes management: A qualitative evidence
synthesis.
Diabet Med. 2025 Mar 20:e70016. doi: 10.1111/dme.70016.
PubMed
Abstract available
Management of Concurrent Immune Thrombocytopenia and Ulcerative Colitis: A Case
Report and Literature Review.
Intern Med. 2025;64:1569-1573.
PubMed
Abstract available
Latent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Uncovered in a
Case of IgA Nephropathy and Primary Biliary Cholangitis: Clinical and
Histological Insights.
Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5217.
PubMed
Abstract available
A Case of Gastrointestinal Perforation in Guillain-Barre Syndrome.
Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5190.
PubMed
Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity
in women with recurrent pregnancy losses.
J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
PubMed
Abstract available
Randomized controlled trials for multiple sclerosis: integrating pathology-driven
outcomes to capture therapeutic efficacy.
J Neurol. 2025;272:385.
PubMed
Hashimoto's encephalopathy with diffuse leukoencephalopathy: serial MRI and gait
analysis.
J Neurol. 2025;272:399.
PubMed
Relapse risk after rituximab discontinuation in neuromyelitis optica spectrum
disorders: a multi-center retrospective cohort study.
J Neurol. 2025;272:387.
PubMed
Abstract available
Clinical integration of brain and cord MRI features improves differential
diagnosis of multiple sclerosis.
J Neurol. 2025;272:388.
PubMed
Abstract available
Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a
one-year follow-up study.
J Neurol. 2025;272:398.
PubMed
Abstract available
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life
experience.
J Neurol. 2025;272:396.
PubMed
Abstract available
The role of serum neurofilament light (sNfL) as a biomarker in multiple
sclerosis: insights from a systematic review.
J Neurol. 2025;272:400.
PubMed
Abstract available
Various Regimens for Autoimmune Hepatitis in Northern European Children Show
Equivalent Outcomes at 1 Year: A Retrospective Study.
J Pediatr. 2025 May 7:114635. doi: 10.1016/j.jpeds.2025.114635.
PubMed
Abstract available
Chronotype, sleep, and glycemic control in children and adolescents with type 1
diabetes: a case-control study.
J Pediatr Endocrinol Metab. 2025;38:442-449.
PubMed
Abstract available
Relationships among biological sex, body composition, and bone mineral density in
young persons with and without diabetes.
J Pediatr Endocrinol Metab. 2025;38:476-487.
PubMed
Abstract available
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue
Disease.
J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463.
PubMed
Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in
Giant Cell Arteritis?
J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423.
PubMed
Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses:
Successful Treatment With Anti-Interleukin 1 Therapy.
J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036.
PubMed
OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor
Necrosis Factor Inhibitor Therapy: A Rare Case Report.
J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141.
PubMed
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
N Engl J Med. 2025;392:1976.
PubMed
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
N Engl J Med. 2025;392:1975.
PubMed
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy. Reply.
N Engl J Med. 2025;392:1976.
PubMed
Progress toward Mitigating Disability Progression in Multiple Sclerosis.
N Engl J Med. 2025;392:1966-1968.
PubMed
Genetic susceptibility determines Epstein-Barr-virus-associated risk of multiple
sclerosis.
Nat Rev Neurol. 2025 May 12. doi: 10.1038/s41582-025-01099.
PubMed
Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People
With Multiple Sclerosis.
Neurology. 2025;104:e213650.
PubMed
Abstract available
Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by
serum neurofilament light chain concentration in a model of neuroimmune-driven
neurodegenerative disease.
PLoS One. 2025;20:e0322199.
PubMed
Abstract available
Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic
review.
PLoS One. 2025;20:e0323642.
PubMed
Abstract available
Thank you for your interest in scientific medicine.